Delivery Order SPE2DB22D2211-SPE2DB25FSBDC
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Gemtesa 75 mg, with a ceiling value of $15,610.65 under a firm fixed-price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,253.69 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $5,190.53 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gemtesa 75 mg tablets, a medication used to treat overactive bladder. The award has a ceiling value of $4,564.67 and a completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Gemtesa 75 mg tablets. The contract has a ceiling value of $5,910.84 and a completion date of June 11, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets. The contract has a ceiling value of $28,536.37 and runs from August 1, 2024 to August 2, 2024. It is a firm-fixed price contract and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will be responsible for delivering the medication to DLA. This contract is likely part of a larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,565 to Amerisourcebergen Drug Corporation for 75mg Gemtesa tablets. Under this order, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania by July 12, 2023. No additional details were provided regarding the original solicitation or whether this award was issued against an existing contract vehicle. The Defense Logistics Agency manages the global supply chain for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Gemtesa 75 mg tablets. The $12,956.42 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 23, 2024. This delivery order is part of AmerisourceBergen's existing contract with DLA to supply pharmaceuticals and medical supplies in support of military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gemtesa 75 mg Tablets (90 count) at a firm fixed price of $26,979.93. The delivery order has a completion date of September 11, 2024. The award is likely part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $21,007.14 to Amerisourcebergen Drug Corporation to supply 4561867869 GEMTESA 75 MG TABLET 30S. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle with Amerisourcebergen Corporation and will be performed in Conshohocken, Pennsylvania by August 21, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the Defense...